These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term stable expanded human CD4+ T cell clones specific for human cytomegalovirus are distributed in both CD45RAhigh and CD45ROhigh populations. Weekes MP; Wills MR; Sissons JG; Carmichael AJ J Immunol; 2004 Nov; 173(9):5843-51. PubMed ID: 15494538 [TBL] [Abstract][Full Text] [Related]
5. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus. Solache A; Morgan CL; Dodi AI; Morte C; Scott I; Baboonian C; Zal B; Goldman J; Grundy JE; Madrigal JA J Immunol; 1999 Nov; 163(10):5512-8. PubMed ID: 10553078 [TBL] [Abstract][Full Text] [Related]
6. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects. Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198 [TBL] [Abstract][Full Text] [Related]
7. Rapid generation of CMV pp65-specific T cells for immunotherapy. Bao L; Sun Q; Lucas KG J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296 [TBL] [Abstract][Full Text] [Related]
8. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells. Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452 [TBL] [Abstract][Full Text] [Related]
9. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. Scognamiglio P; Accapezzato D; Casciaro MA; Cacciani A; Artini M; Bruno G; Chircu ML; Sidney J; Southwood S; Abrignani S; Sette A; Barnaba V J Immunol; 1999 Jun; 162(11):6681-9. PubMed ID: 10352286 [TBL] [Abstract][Full Text] [Related]
10. Characterization of host immunity to cytomegalovirus pp150 (UL32). La Rosa C; Wang Z; Lacey SF; Markel SF; Sharma MC; Martinez J; Lalimarmo MM; Diamond DJ Hum Immunol; 2005 Feb; 66(2):116-26. PubMed ID: 15694996 [TBL] [Abstract][Full Text] [Related]
11. CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection. McFarland HI; Nahill SR; Maciaszek JW; Welsh RM J Immunol; 1992 Aug; 149(4):1326-33. PubMed ID: 1500720 [TBL] [Abstract][Full Text] [Related]
12. Large HIV-specific CD8 cytotoxic T-lymphocyte (CTL) clones reduce their overall size but maintain high frequencies of memory CTL following highly active antiretroviral therapy. Weekes MP; Wills MR; Sissons JG; Carmichael AJ Immunology; 2006 May; 118(1):25-38. PubMed ID: 16630020 [TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus. Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550 [TBL] [Abstract][Full Text] [Related]
14. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876 [TBL] [Abstract][Full Text] [Related]
15. CMV-specific central memory T cells reside in bone marrow. Letsch A; Knoedler M; Na IK; Kern F; Asemissen AM; Keilholz U; Loesch M; Thiel E; Volk HD; Scheibenbogen C Eur J Immunol; 2007 Nov; 37(11):3063-8. PubMed ID: 17960663 [TBL] [Abstract][Full Text] [Related]
16. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Champagne P; Ogg GS; King AS; Knabenhans C; Ellefsen K; Nobile M; Appay V; Rizzardi GP; Fleury S; Lipp M; Förster R; Rowland-Jones S; Sékaly RP; McMichael AJ; Pantaleo G Nature; 2001 Mar; 410(6824):106-11. PubMed ID: 11242051 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection. McNally JM; Dempsey D; Wolcott RM; Chervenak R; Jennings SR J Immunol; 1999 Jul; 163(2):675-81. PubMed ID: 10395657 [TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. Kern F; Bunde T; Faulhaber N; Kiecker F; Khatamzas E; Rudawski IM; Pruss A; Gratama JW; Volkmer-Engert R; Ewert R; Reinke P; Volk HD; Picker LJ J Infect Dis; 2002 Jun; 185(12):1709-16. PubMed ID: 12085315 [TBL] [Abstract][Full Text] [Related]
19. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation. Luo XH; Huang XJ; Liu KY; Xu LP; Liu DH Biol Blood Marrow Transplant; 2010 Jul; 16(7):994-1004. PubMed ID: 20167279 [TBL] [Abstract][Full Text] [Related]
20. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes. de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]